Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

JHSPE. 2022; 2(1): 24-27


Importance of newer molecular test for diagnosis of Gaucher disease, a rare condition

Rahul Tandon, Rajesh Naranbhai Pankhaniya, Nishant Dharsandia, Megha Anant.




Abstract
Cited by 0 Articles

Gaucher’s disease is an autosomal recessive systemic lysosomal storage disorder, characterized by glucocerebroside deposition in cells of the macrophage-monocyte system as a result of deficiency of lysosomal acid beta-glucosidase(glucocerebrosidase). It is a rare genetic disorder and the most common among lysosomal storage disorders. Accumulation of glucocerebroside in tissues leads to multisystem organ involvement viz. liver, spleen, bone marrow, lungs, and central nervous system. It is common in Ashkenazi Jews but rare in India. Gaucher’s disease is a slowly progressive multisystem disease so it is difficult to diagnose early as it can be confused with so many differential diagnoses like hemolytic anemia, hematological malignancies, and chronic liver disease with portal hypertension. Detailed history, complete examination, and basic laboratory investigations are of prime importance to diagnose Gaucher’s disease early.

Key words: Ashkenazi Jews, Glucocerebrosidase, lysosomal storage disorders






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.